Future work should be extended to develop a recurrence stratification system that incorporates clinical factors, biochemical parameters (PTH, calcium level), pathological evidence (microscopic and macroscopic invasion), genetic defects (mutations and/or loss of the CDC73 tumor suppressor gene, which has been recognized to be the main genetic defects of PC) and other anatomical factors. This evidence concerns the gene CDC73 and pachyonychia congenita.